Healthcare provider profile · identity verified

Shannon Renae Wright, FNP

Nurse Practitioner · BELLE, MO · NPI 1619033404

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	507	100
Lisinopril	Lisinopril	476	97
Amlodipine Besylate	Amlodipine Besylate	281	62
Pantoprazole Sodium	Pantoprazole Sodium	275	50
Potassium Chloride	Potassium Chloride	265	53
Levothyroxine Sodium	Levothyroxine Sodium	262	48
Furosemide	Furosemide	238	49
Omeprazole	Omeprazole	238	52
Losartan Potassium	Losartan Potassium	215	49
Gabapentin	Gabapentin	198	55
Metoprolol Tartrate	Metoprolol Tartrate	191	36
Montelukast Sodium	Montelukast Sodium	181	33
Sertraline Hcl	Sertraline Hcl	171	37
Rosuvastatin Calcium	Rosuvastatin Calcium	156	37
Famotidine	Famotidine	144	30
Metoprolol Succinate	Metoprolol Succinate	135	33
Tamsulosin Hcl	Tamsulosin Hcl	131	27
Albuterol Sulfate Hfa	Albuterol Sulfate	126	47
Carvedilol	Carvedilol	126	22
Hydrochlorothiazide	Hydrochlorothiazide	125	34
Clopidogrel	Clopidogrel Bisulfate	116	27
Venlafaxine Hcl Er	Venlafaxine Hcl	110	16
Allopurinol	Allopurinol	107	25
Metformin Hcl	Metformin Hcl	105	22
Simvastatin	Simvastatin	104	21
Pravastatin Sodium	Pravastatin Sodium	102	23
Duloxetine Hcl	Duloxetine Hcl	98	21
Trazodone Hcl	Trazodone Hcl	97	26
Glimepiride	Glimepiride	92	18
Escitalopram Oxalate	Escitalopram Oxalate	91	18
Tramadol Hcl	Tramadol Hcl	89	31
Prednisone	Prednisone	86	54
Bupropion Xl	Bupropion Hcl	82	17
Citalopram Hbr	Citalopram Hydrobromide	80	19
Jardiance	Empagliflozin	79	14
Alendronate Sodium	Alendronate Sodium	75	24
Atenolol	Atenolol	75	16
Metformin Hcl Er	Metformin Hcl	75	17
Fluticasone Propionate	Fluticasone Propionate	74	32
Lovastatin	Lovastatin	74	13
Quetiapine Fumarate	Quetiapine Fumarate	74	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	30
Donepezil Hcl	Donepezil Hcl	73	18
Fluoxetine Hcl	Fluoxetine Hcl	71	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	70	13
Meloxicam	Meloxicam	70	24
Clonazepam	Clonazepam	65	14
Glipizide	Glipizide	65	suppressed
Mounjaro	Tirzepatide	62	12
Finasteride	Finasteride	59	11
Cefdinir	Cefdinir	53	41
Warfarin Sodium	Warfarin Sodium	52	suppressed
Xarelto	Rivaroxaban	52	suppressed
Eliquis	Apixaban	50	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	suppressed
Pregabalin	Pregabalin	49	13
Ropinirole Hcl	Ropinirole Hcl	49	14
Doxycycline Hyclate	Doxycycline Hyclate	48	38
Topiramate	Topiramate	46	suppressed
Doxepin Hcl	Doxepin Hcl	42	suppressed
Ozempic	Semaglutide	41	suppressed
Paroxetine Hcl	Paroxetine Hcl	41	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	41	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	38	38
Zonisamide	Zonisamide	38	suppressed
Azithromycin	Azithromycin	37	29
Hydroxyzine Hcl	Hydroxyzine Hcl	36	16
Trulicity	Dulaglutide	36	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Levetiracetam	Levetiracetam	34	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	24
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Fluconazole	Fluconazole	29	16
Vancomycin Hcl	Vancomycin Hcl	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Methylprednisolone	Methylprednisolone	25	20
Naproxen	Naproxen	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	13
Buspirone Hcl	Buspirone Hcl	19	suppressed
Amoxicillin	Amoxicillin	18	15
Celecoxib	Celecoxib	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Linzess	Linaclotide	18	suppressed
Nystatin	Nystatin	18	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Mupirocin	Mupirocin	17	17
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	14
Ezetimibe	Ezetimibe	16	suppressed
Cephalexin	Cephalexin	15	14
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Cefuroxime	Cefuroxime Axetil	13	12
Januvia	Sitagliptin Phosphate	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Novolin N	Insulin Nph Human Isophane	12	suppressed
Prasugrel Hcl	Prasugrel Hcl	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error